For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

MONTREAL, Jan. 14, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that eligible patients in Ontario now have access to Pluvicto™ (lutetium (177 Lu ...

The session delved into the intricacies of HoLEP, a minimally invasive surgical technique that utilizes a holmium laser to remove excess prostate tissue precisely. Dr. Manohar Bhadrappa, Senior ...

Ontario's health minister says the province will now publicly fund a new treatment for advanced-stage prostate cancer. Health Canada approved Pluvicto in August 2022, but patients have been ...

“Our government is proud to be the first in Canada to administer a publicly funded dose of PLUVICTO TM, a lifesaving treatment for advanced-stage prostate cancer, now publicly funded for patients ...

Removal of the prostate gland can leave a risk of erectile dysfunction. Recently, experts performed the world's first ...

No growth? No treatment. If treatment is needed, the most common treatments are radiation therapy and surgery to remove the prostate gland. The operation usually eliminates an organ-confined ...

Most men over 50 will develop an enlarged prostate. Also called benign prostatic hyperplasia, this bothersome condition makes it hard to urinate and can eventually lead to other problems, such as ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research ...

Ortel, the California-based supplier of optical communications components now owned by Photonics Foundries, says it has transferred production of its flagship C-Band laser diode to the Canadian ...

The Nanaimo and District Hospital Foundation doesn't have a SPECT-CT machine funded quite yet, but due to winter donations, ...